Synthesis, characterization, antioxidant and anticancer evaluation of some novel flavone-4-oximes  by Jayashree, B.S. et al.
Synthesis, characterization, antioxidant and
anticancer evaluation of some novel
flavone-4-oximes
B.S. Jayashree *, Sri Gurushyam, Aravinda Pai
Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka,
576104, India
A R T I C L E I N F O
Article history:
Available online 25 November 2015
Keywords:
Flavone oxime
Antioxidant
Anticancer
HepG
MCF
A series of novel flavone-4-oximes [1] were synthesized by the
oximation of substituted flavones. The synthesized com-
pounds were characterized by various spectroscopic methods
including IR, MASS, NMR spectroscopy. Out of the 14 test com-
pounds screened for their antioxidant activity, compounds such
as JGS-VI (a N,N dimethyl benzaldehyde derivative) and JGS-
VII (a 3,4 dimethoxy benzaldehyde derivative) exhibited
antioxidant activity comparable to that of ascorbic acid with
its IC50 value at 30.01 Mm as standard following DPPH∙ method.
Compounds such as JGS-II (a Para fluro benzaldehyde deriva-
tive), JGS-IV (a Para methyl benzaldehyde derivative) and JGS-V
(a thiophene -2-aldehyde derivative) exhibited anti-oxidant ac-
tivity among all the test compounds screened against ABTS
[2] using Quercetin with its IC50 value at 50.24 Mm. However,
none of them showed any significant scavenging activity against
nitric oxide scavenging assay in the concentration range of
200 μM–25 Μm.
Further, anti-cancer potency for all the test compounds were
evaluated by MTT [3] assay against two different cell line such
as MCF-7 and Hep-G2. Compounds such as JGS-I(a para chloro
benzaldehyde derivative), JGS-II (a Para fluro benzaldehyde de-
rivative), JGS-IV (a Para methyl benzaldehyde derivative), JGS-V
(a thiophene -2-aldehyde derivative), JGS-VI (a N,N dimethyl
benzaldehyde derivative) and JGS-IX (a 3,4 dichloro benzalde-
hyde derivative) exhibited activity better than the rest of the
other test compounds tested against MCF-7 cell lines and were
compared with Doxorubicin with its IC50 value at 4.2 μM. Com-
pounds such as JGS-VI, JGS-VII, JGS-VIII (a Para bromo
benzaldehyde derivative) and JGS-IX exhibited anti-cancer ac-
tivity better than other test compounds tested against Hep-
G2 cell lines. The standard used was Doxorubicin. Thus, a few
of the synthesized test compounds could become promising
anti-cancer agents.
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Fig. 1–NMR spectra of target compound JGS XIII.
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